The promise of combining radiation therapy and immunotherapy: morbidity and toxicity.
about
Radiobiology of stereotactic body radiation therapy (SBRT).Combination Treatment with Sublethal Ionizing Radiation and the Proteasome Inhibitor, Bortezomib, Enhances Death-Receptor Mediated Apoptosis and Anti-Tumor Immune Attack.Minimizing morbidity in radiation oncology: a special issue from Future Oncology.
P2860
The promise of combining radiation therapy and immunotherapy: morbidity and toxicity.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The promise of combining radiation therapy and immunotherapy: morbidity and toxicity.
@en
The promise of combining radiation therapy and immunotherapy: morbidity and toxicity.
@nl
type
label
The promise of combining radiation therapy and immunotherapy: morbidity and toxicity.
@en
The promise of combining radiation therapy and immunotherapy: morbidity and toxicity.
@nl
prefLabel
The promise of combining radiation therapy and immunotherapy: morbidity and toxicity.
@en
The promise of combining radiation therapy and immunotherapy: morbidity and toxicity.
@nl
P2093
P2860
P356
P1433
P1476
The promise of combining radiation therapy and immunotherapy: morbidity and toxicity.
@en
P2093
Andre M Agassi
Constantine A Mantz
Daniel E Dosoretz
Eduardo Fernandez
Francisco A Myslicki
Jesse M Shulman
Steven E Finkelstein
Yosef Rotterman
P2860
P304
P356
10.2217/FON.14.188
P407
P577
2014-12-01T00:00:00Z